Hem › Autoimmuna sjukdomar › Texas › Dallas
Kliniska studier för Autoimmuna sjukdomar i Dallas, TX
9 studier för Autoimmuna sjukdomar söker deltagare vid platser i och runt Dallas (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekryterarFas 1
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RekryterarFas 2/3
- University of Texas Southwestern Medical Center - Accepting Juvenile Patients, Dallas
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RekryterarFas 3
- Dallas Renal Group, Dallas
- Dallas Renal Group, Dallas
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RekryterarFas 3
- UT Southwestern Medical Center, Dallas
Study of BHV-1300 in Graves' Disease
RekryterarFas 1
- Site-109, Dallas
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RekryterarFas 3
- Site Number - 1003, Dallas
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
RekryterarFas 1/2
- UT Southwestern Medical Center, Dept. of Dermatology, Dallas
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RekryterarFas 1
- UT Southwestern Medical Center, Dallas
Autoimmuna sjukdomar-studier i andra städer
- Houston, TX21 studier
- Washington, DC19 studier
- New York City, NY19 studier
- Philadelphia, PA16 studier
- Durham, NC15 studier
- Boston, MA13 studier
- Los Angeles, CA12 studier
- Chicago, IL12 studier
- Cleveland, OH8 studier
- Milwaukee, WI8 studier
- Atlanta, GA8 studier
- Portland, OR8 studier
Andra studier i Dallas
- Bröstcancer55 studier
- Icke-småcellig lungcancer52 studier
- Metastaserande cancer42 studier
- Hjärtsvikt42 studier
- Cancer (alla typer)37 studier
- Prostatacancer36 studier
- Kolorektal cancer33 studier
- Övervikt30 studier
- Äggstockscancer28 studier
- Blåscancer27 studier
- Lungcancer27 studier
- Endometriecancer24 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.